Therefore, this study has completed the construction of dual-recognition specific antibodies (anti-EGFR antibody for pancreatic cancer cells and anti-FAP for fibroblasts surrounding pancreatic cancer cells), which remove the Fc fragment and preserve the specific target region, Fv fragments. This evidence concerns the gene EGFR and familial pancreatic carcinoma.